Company: ARWR
Filing Date: 2025-11-25
Form Type: 10-K
Source: 0000879407-25-000029
Chunk: 137

Company: ARROWHEAD PHARMACEUTICALS, INC.
Filing Date: 2025-11-25
Form: 10-K
Item: Item 5
Chunk 137
---
 on September 30, 2020 in each of the Company’s common stock, the Nasdaq Composite Index and the Nasdaq Biotechnology Index, with investment weighted on the basis of market capitalization.

61

The comparisons in the following graph are based on historical data and are not intended to forecast the possible future performance of the Company’s common stock.

$100 investment in stock or indexTicker202020212022202320242025Arrowhead Pharmaceuticals, Inc.ARWR$152.80 $221.54 $117.28 $95.35 $68.74 $122.39 NASDAQ Biotechnology Index^NBI$136.10 $162.58 $120.46 $126.41 $152.44 $156.02 NASDAQ Composite Index^IXIC$139.61 $180.62 $132.21 $165.26 $227.38 $283.27